Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, characterized by extremely complex pathogenetic mechanisms and multifactorial etiologies. Oxidative stress, impaired mitochondrial metabolism, inflammation, gut microbiota, and regulation of the hepatic lipid metabolism by the brain-liver-axis are major pathophysiological mechanisms leading to NAFLD. The emerging therapeutic approaches for NAFLD target these pathophysiological pathways to achieve better clinical outcomes.
To gain detailed insights into the latest developments in the management of NAFLD, join the reputed Gastroenterologist, Dr. Pallavi Garg , in our exclusive webinar on 6 th April 2023 , 3:00 PM IST onwards . Session Highlights Deeper insights into the latest thinking in NAFLD/NASH research The cutting-edge developments and future of the NAFLD area Measures to overcome the growing…
